Colorectal carcinoma in children and adolescents: The experience of the Istituto Nazionale Tumori of Milan, Italy

Pediatric Blood and Cancer

Volumn 50, Issue 3, 2008, Pages 588-593

  Ferrari, Andrea ^a   Rognone, Alessia ^a   Casanova, Michela ^a   Zaffignani, Elena ^a   Piva, Luigi ^a   Collini, Paola ^a   Bertario, Lucio ^a   Sala, Paola ^a   Leo, Ermanno ^a   Belli, Filiberto ^a   Gallino, Gianfranco ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Children and adolescents; Colorectal carcinoma; Rare pediatric tumors; Young adults

Indexed keywords

CAPECITABINE; DOXORUBICIN; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MITOMYCIN; OXALIPLATIN;

ADOLESCENT; ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILDHOOD CANCER; CLINICAL ARTICLE; COLORECTAL CANCER; FEMALE; HEMICOLECTOMY; HUMAN; ITALY; MALE; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; SIGMOIDECTOMY;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; ADENOMATOUS POLYPOSIS COLI; ADOLESCENT; ADULT; AGE OF ONSET; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; CHILD; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; ITALY; MALE; NEOPLASMS, SECOND PRIMARY; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 38549132356     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21220     Document Type: Article

References (55)

1. Pappo AS, Furman WL. Management of infrequent cancers in childhood. In: Pizzo PA, Poplack DC, editors. Principles and Practice of Pediatric Oncology, 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2006. pp 1172-1201.
2. Ries LEM, Kosary C, Hankey B, et al. SEER cancer statistic review. 1975-2001. 2004.
3. Fairley TL, Cardinez CJ, Martin J, et al. Colorectal cancer in U.S. adults younger than 50 years of age, 1998-2001. Cancer 2006;107:1153-1161.
4. Rao BN, Pratt CB, Fleming ID, et al. Colon carcinoma in children and adolescents. A review of 30 cases. Cancer 1985;55:1322-1326.
5. Lamego CM, Torloni H. Colorectal adenocarcinoma in childhood and adolescence. Report of 11 cases and review of the literature. Pediatr Radiol 1989;19:504-508.
6. Taguchi T, Suita S, Hirata Y, et al. Carcinoma of the colon in children: A case report and review of 41 Japanese cases. J Pediatr Gastroenterol Nutr 1991;12:394-399.
7. LaQuaglia MP, Heller G, Filippa DA, et al. Prognostic factors and outcome in patients 21 years and under with colorectal carcinoma. J Pediatr Surg 1992;27:1085-1089.
8. Brown RA, Rode H, Millar AJ, et al. Colorectal carcinoma in children. J Pediatr Surg 1992;27:919-921.
9. Cozart DT, Lang NP, Hauer-Jensen M. Colorectal cancer in patients under 30 years of age. Contributors to the Southwestern Surgical Congress Unusual Case Registry. Am J Surg 1993;166:764-767.
10. Rodriguez-Bigas MA, Mahoney MC, Weber TK, et al. Colorectal cancer in patients aged 30 years or younger. Surg Oncol 1996;5:189-194.
11. Shahrudin MD, Noori SM. Cancer of the colon and rectum in the first three decades of life. Hepatogastroenterology 1997;44:441-444.
12. Sebbag G, Lantsberg L, Arish A, et al. Colon carcinoma in the adolescent. Pediatr Surg Int 1997;12:446-448.
13. Chung YF, Eu KW, Machin D, et al. Young age is not a poor prognostic marker in colorectal cancer. Br J Surg 1998;85:1255-1259.
14. Karnak I, Ciftci AO, Senocak ME, et al. Colorectal carcinoma in children. J Pediatr Surg 1999;34:1499-1504.
15. Pratt CB, Rao BN, Merchant TE, et al. Treatment of colorectal carcinoma in adolescents and young adults with surgery, 5-fluorouracil/leucovorin/ interferon-alpha 2a and radiation therapy. Med Pediatr Oncol 1999;32:459-460.
16. Bhatia S, Pratt CB, Sharp GB, et al. Family history of cancer in children and young adults with colorectal cancer. Med Pediatr Oncol 1999;33:470-475.
17. Sule AZ, Mandong BM. Malignant colorectal tumours in patients 30 years and below: A review of 35 cases. Cent Afr J Med 1999;45:209-212.
18. Vastyan AM, Walker J, Pinter AB, et al. Colorectal carcinoma in children and adolescents - a report of seven cases. Eur J Pediatr Surg 2001;11:338-341.
19. Chen LK, Hwang SJ, Li AF, et al. Colorectal cancer in patients 20 years old or less in Taiwan. South Med J 2001;94:1202-1205.
20. Stones DK, McGill N. Colon carcinoma in African children. Med Pediatr Oncol 2003;40:410-411.
21. Radhakrishnan CN, Bruce J. Colorectal cancers in children without any predisposing factors. A report of eight cases and review of the literature. Eur J Pediatr Surg 2003;13:66-68.
22. Durno C, Aronson M, Bapat B, et al. Family history and molecular features of children, adolescents, and young adults with colorectal carcinoma. GUT 2005;54:1146-1150.
23. Chantada GL, Perelli VB, Lombardi MG, et al. Colorectal Carcinoma in children, adolescents, and young adults. J Pediatr Hematol Oncol 2005;27:39-41.
24. Andersson A, Bergdahl L. Carcinoma of the colon in children: A report of six new cases and a review of the literature. J Pediatr Surg 1976;11:967-971.
25. Toki A, Todani T, Watanabe Y, et al. Carcinoma of the colon in childhood; report of two cases expressing p53 without K-ras mutation. Eur J Pediatr Surg 1997;7:315-317.
26. Endreseth BH, Romundstad P, Myrvold HE, et al. Rectal cancer in the young patients. Dis Colon Rectum 2006;49:993-1001.
27. Goldthorn JF, Powars D, Hays DM. Adenocarcinoma of the colon and rectum in the adolescents. Surgery 1983;93:409-414.
28. Jerkie S, Rosewitch H, Scharf JG, et al. Colorectal cancer in two pre-teenage siblings with familial adenomatous polyposis. Eur J Pediatr 2005;164:306-310.
29. Kam MH, Eu KW, Barben CP, et al. Colorectal cancer in the young: A 12 year review of patients 30 years or less. Colorectal Disease 2004;6:191-194.
30. Lee PY, Fletcher WS, Sullivan ES, et al. Colorectal cancer in young patients: Characteristics and outcome. Am Surg 1994;60:607-612.
31. Minardi AJ Jr, Sittig KM, Zibari GB, et al. Colorectal cancer in the young patients. Am Surg 1998;64:849-853.
32. Turnbull RB Jr, Kyle K, Watson FR, et al. Cancer of the colon: The influence of the no-touch isolation technique on survival rates. Ann Surg 1967;166:420-427.
33. th ed. New York: Springer-Verlag; 2002.
34. Kaplan E, Meier P. Non-parametric estimation from incomplete observation. J Am Stat Assoc 1958;53:457-481.
35. Vasen HF, Watson P, Mecklin JP, et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology 1999;116:1453-1456.
36. Ferrari A, Bisogno G, De Salvo GL, et al. The challenge of very rare tumours in childhood: the Italian TREP project. Eur J Cancer 2006; [Epub ahead of print].
37. Bertario L, Russo A, Sala P, et al. Survival of patients with hereditary colorectal cancer: Comparison of HNPCC and colorectal cancer in FAP patients with sporadic colorectal cancer. Int J Cancer 1999;80:183-187.
38. Mitry E, Benhamiche AM, Jouve JL, et al. Colorectal adenocarcinoma in patients under 45 years of age: Comparison with older patients in a well-defined French population. Dis Colon Rectum 2001;44:380-387.
39. Zorluoglu A, Yilmazlar T, Ozguc H, et al. Colorectal cancers under 45 years of age. Hepatogastroenterology 2004;51:118-120.
40. Pratt CB. Epidemic colon cancer in children and adolescents?. In: Correa PHW, editor. Epidemiology of cancer of the digestive tract. The Hague/Boston/London: Mertinus Nijhoff; 1982. 127-146.
41. Pratt CB, Rivera G, Shanks E, et al. Colorectal carcinoma in adolescents: Implications regarding etiology. Cancer 1977;40:2464-2472.
42. Kim HC, Kim CN, Yu CS, et al. Methylation of the hMLH1 and hMSH2 promoter in early-onset sporadic colorectal carcinomas with microsatellite instability. Int J Colorectal Dis 2003;18:196-202.
43. Madajewicz S, Petrelli N, Rustum YM, et al. Phase I-II trial of high-dose calcium leucovorin and 5-fluorouracil in advanced colorectal cancer. Cancer Res 1984;44:4667-4669.
44. Minsky BD, Cohen AM, Enker WE, et al. Efficacy of postoperative 5-FU, high-dose leucovorin, and sequential radiation therapy for clinically resectable rectal cancer. Cancer Invest 1995;13:1-7.
45. Rothenberg ML, Oza AM, Bigelow RH, et al. Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: Interim results of a phase III trial. J Clin Oncol 2003;21:2059-2069.
46. Goyle S, Maraveyas A. Chemotherapy for colorectal cancer. Dig Surg 2005;22:401-414.
47. Saltz LB, Cox JV, Blanke C, et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 2000;343:905-914.
48. Minsky BD, Cohen AM, Enker WE, et al. Preoperative 5-FU, low-dose leucovorin, and radiation therapy for locally advanced and unresectable rectal cancer. Int J Radiat Oncol Biol Phys 1997;37:289-295.
49. Minsky BD, Cohen AM, Kemeny N, et al. Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy. J Clin Oncol 1992;10:79-84.
50. Fearon ER. Human cancer syndromes: Clues to the origin and nature of cancer. Science 1997;278:1043-1050.
51. Lynch HT, Smyrk T, Lynch J. An update of HNPCC (Lynch syndrome). Cancer Genet Cytogenet 1997;93:84-99.
52. Raedle J, Trojan J, Brieger A, et al. Bethesda guidelines: Relation to microsatellite instability and MLH1 promoter methylation in patients with colorectal cancer. Ann Intern Med 2001;135:566-576.
53. Leppert M, Dobbs M, Scambler P, et al. The gene for familial polyposis coli maps to the long arm of chromosome 5. Science 1987;238:1411-1413.
54. Losi L, Di Gregorio C, Pedroni M, et al. Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes. Am J Gastroenterol 2005;100:2280-2287.
55. Pinto C, Veiga I, Pinheiro M, et al. MSH6 germline mutations in early-onset colorectal cancer patients without family history of the disease. Br J Cancer 2006;95:752-756.